{"prompt": "['Alliance A221701', 'significance of p<10-8 (Table 1). Six other SNPs that showed some association with', 'everolimus after functional studies were reported in the same study (Table 1). The most', 'significant gene whose expression has been reported to associate with everolimus', 'sensitivity is FBXW7, p=4x10-7.48 This FBXW7 gene encodes a member of the F-box', 'protein family and functions by binding directly to multiple substrates including cyclin E', 'and targeting cyclin E for ubiquitin-mediated degradation 49,50 Other substrates include c-', 'Myc, c-Jun, Notch, Mcl-1 and mammalian target of rapamycin (mTOR)51 all of which', 'are', 'involved in cell division, growth, survival and differentiation 50,52,53', 'FBXW7', 'also', 'functions', 'as a tumor suppressor and inactivation of the protein is associated with deregulation of well', '-known oncoproteins some of which are indicated above 51,52 and is also one of the most', 'frequently mutated genes in human cancers. 49,51 FBXW7 is genetically polymorphic', 'although no SNP was observed in the GWAS study48 However, polymorphisms in this', 'gene have been reported in relation to blood pressure 55and epilepsy56 As such, we', 'will', 'derive tagSNPs for FBXW7 and explore correlations of the polymorphisms with stomatiti.', 'Given that the SNPs mentioned here (see also Table 1 : SNPs1 - 16, 22-26) have previously', 'been associated with everolimus and everolimus sensitivity (indicated above) and that oral', 'mIAS results from sensitivity to everolimus intake, we will investigate these SNPs in this', 'study to determine if they appear to predispose patients to different levels of stomatitis', 'severity. In addition, we will explore any correlations that the FBXW7 tagSNPs we derive', 'will have on stomatitis severity. Moreover since the study proposes the use of', 'dexamethasone to substantially decrease severity in mIAS-associated pain in the patients', 'on treatment, we will evaluate if the use of dexamethasone changes any observed mIAS-', 'SNP associations in the study.', 'Therefore, we will validate SNPs that have been associated with everolimus sensitivity by', 'associating them with severity of stomatitis. TagSNPs for FBXW7 will be explore for their', 'associations with stomatitis severity. We propose to do this by following the objectives', 'below:', '14.1.2 Objectives', '1) To derive tagSNPs for FBXW7 and together with SNPs reported (Table 1), genotype', 'all patient samples for those SNPs', '2) To explore the association of the genotypes with severity of everolimus-related', 'stomatitis (mlAS-', 'associated pain) within the patients who initially received placebo', 'at the start of everolimus treatment.', '3)', 'To explore the association of the genotypes with severity of everolimus-related', 'stomatitis (mlAS-', 'associated pain) within the patients who initially received', 'dexamethasone at the start of everolimus treatment.', '14.1.3 Methods', 'DNA Isolation, SNP selection and Genotyping:', 'Whole blood sample will be collected in 1 x10 mL EDTA vacutainer tube (purple top)', 'from patients at start of study for germline DNA isolation. Blood samples will be sent to', 'the Alliance Biorepository at Mayo Clinic and DNA will be isolated in the Biospecimen', 'Accessioning and Processing (BAP) laboratory.', 'SNP selection for FBXW7: Genotype data from the National Center for Biotechnology', 'Information (NCBI) dbSNP database will be used with programs in National Institute of', 'environmental Health Sciences', 'and Genome variation', '52', 'NCI version date 8/14/2020', 'Update #03']['Alliance A221701', 'server', 'to derive tagged SNPs for FBXW7 with', 'allele frequencies of at least 10% and r2 > 0.80 (Table 1, SNP # 17-21).', 'Genotyping: The acquired tagSNPs and the rest of the SNPs in Table 1 will be genotyped', 'in the Genotyping Core of the Mayo Clinic Medical Genome Facility (MGF).', 'Table 1', 'SNP', 'Global', 'Global', 'SNP ID', 'Allele', 'Chr', '#', 'Reported/Mapped Gene', 'Context', 'MA', 'MAF', '1', 'rs218869', 'A>T', '8', 'Intergenic/LOC107986930', 'Intron variant', 'T', '0.33', '2', 'rs7694207', 'OT', '4', 'MGC46496/COX7A2P2 -STPG2-AS1 -', 'Flanking, 3UTR', 'T', '0.29', '3', 's10987149', 'A>G', '9', 'PBX3', 'Flanking, 3UTR', 'G', '0.35', '4', 's12932018', 'A>G', '16', 'USP10', 'Synonymous, exon', 'G', '0.26', 'variant', '5', 'rs2702449', 'G>A', '4', 'AGA', 'Flanking, 5UTR', 'A', '0.36', '6', 's16887552', 'A>C', '4', 'LOC107986181 - LOC105374493', 'Intergenic variant', 'C', '0.27', '7', 'rs2832270', 'G>A', '21', 'C2lorf7', 'Flanking, 3UTR', 'A', '0.14', '8', 'rs1460196', 'OT', '18', 'DCC', 'Intron variant', 'T', '0.10', '9', 'rs4148330', 'A>G', '16', 'ABCCI', 'Flanking, 5UTR', 'G', '0.47', '10', 'rs13272072', 'OT', '8', 'STCI', 'Flanking, 3UTR', 'T', '0.10', '11', 's17664713', 'OT', '15', 'MCTP2', 'Flanking, 3UTR', 'T', '0.12', '12', 'rs 10870177', 'OT', '9', 'MANIBI', 'Intron variant', 'T', '0.18', '13', 'rs7543260', 'T>C', '1', 'JUN', 'Flanking, 5UTR', 'C', '0.19', '14', 'rs 10780752', 'T>C', '9', 'C9orf153', 'Flanking, 3UTR', 'C', '0.32', '15', 'rs 17732246', 'G>A', '15', 'MCTP2', 'Flanking, 3UTR', 'A', '0.10', '16', 'rs 11075286', 'O>A', '16', 'ABCCI', 'Flanking, 5UTR', 'A', '0.45', 'T>C', 'FBXW7', 'Intergenic upstream', '17', 'rs 6535847', '4', 'C', '0.46', 'variant', '18', 'rs 17361782', 'T>G', '4', 'FBXW7', 'Intron variant', 'G', '0.13', '19', 'rs2255137', 'T>C', '4', 'FBXW7', 'Intron variant', 'C', '0.34', '20', 'rs2714804', 'A>G', '4', 'FBXW7', 'Intron variant', 'G', '0.11', '21', 'rs2714805', 'OT', '4', 'FBXW7', 'Intron variant', 'T', '0.44', '22', 'rs 1045642', 'G>A', '7', 'ABCB1', 'synonymous variant,', 'A', '0.40', 'exon', 'Missense variant,', '23', 'rs351855', 'G>A', '5', 'FGFR4', 'A', '0.30', 'exon', '24', 'rs2024627', 'O>T', '1', 'MTOR', 'Intron variant', 'T', '0.2991', 'Intergenic upstream', '25', 'rs 2295080', 'T>G', '1', 'MTOR', 'G', '0.4623', 'variant', '26', 'rs 1883965', 'G>A', '1', 'MTOR', 'Intron variant', 'A', '0.3063', 'SNP # 1-16: The most significant SNPs observed in the everolimus sensitivity GWAS', 'study (bold font) and SNPs with functional implications from the same study. 48', 'SNP #17-21: derived tagSNPs for FBXW7; SNP # 22-23: Reported everolimus associated', 'SNPs. 44,47', 'Abbreviations: SNP: single nucleotide polymorphism; UTR: untranslated region; MA:', 'minor allele; MAF: minor allele frequency', '14.1.4 Analyses', 'The MAF will be summarized for each of the SNPs listed in Table 1 of section 14.1.3 for', 'objective 1 in section 14.1.2. The primary analysis for objectives 2 and 3 of this correlative', '53', 'NCI version date 8/14/2020', 'Update #03']\n\n###\n\n", "completion": "END"}